In 2019, an unprecedented disease named coronavirus disease 2019 (COVID-19) emerged
and spread across the globe. Although the rapid transmission of COVID-19 has resulted in …

In December 2019, a novel coronavirus, SARS-CoV-2, appeared, causing a wide range of
symptoms, mainly respiratory infection. In March 2020, the World Health Organization …

COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs.
Critically ill patients are easily complicated by cytokine storms, acute respiratory distress …

Background: In the past few years, COVID-19 became the leading cause of morbidity and
mortality worldwide. Although the World Health Organization has declared an end to COVID …

Antifibrotics for COVID-19 related lung fibrosis: agents with benefits? Page 1 LETTER TO THE
EDITOR 231 www.journals.viamedica.pl Address for correspondence: Mayank Mishra, All India …

Abstract Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 rapidly spread across the globe causing over 6 million deaths and major …

At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …

After decades of research, two therapies for chronic fibrotic lung disease are now approved
by the FDA, with dozens more anti-fibrotic therapies in the pipeline. A great deal of …

In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions
worldwide with a high mortality rate due to a lack of definitive treatment. Despite having a …